Showing results (201-210 of 215) with videos related to
Sort By:
Pageof 22
Cancer Immunology, Immunotherapy : CII|April 17, 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomasE Toulemonde, S Chevret, M Battistella, et al.Leukemia|February 20, 2003
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trialS de Botton, S Chevret, V Coiteux, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapyS de Botton, V Coiteux, S Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantationI Yakoub-Agha, P de La Salmonière, P Ribaud, et al.Leukemia|November 25, 2005
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyS de Botton, M A Sanz, S Chevret, et al.Critical Care Medicine|November 9, 2001
Compliance with triage to intensive care recommendationsE Azoulay, F Pochard, S Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia groupS de Botton, A Fawaz, S Chevret, et al.Leukemia|November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceL Ades, S Chevret, S De Botton, et al.Neurology|August 6, 2008
Dehydroepiandrosterone for myotonic dystrophy type 1I Pénisson-Besnier, M Devillers, R Porcher, et al.Blood|August 10, 1999
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL GroupP Fenaux, C Chastang, S Chevret, et al.Pageof 22